Dudnyk news
Dudnyk expands scientific department
The scientific department adds more talent with recent hire of Daniel Zaksas, PhD
As the new Scientific Director at Dudnyk, Daniel Zaksas will oversee the medical content of the agency’s promotional copy. He will report to Christopher Tobias, PhD, Executive Vice President, Chief Scientific Officer and Director of Business Development.
Long live creative! Barry weighs in on regulation and the future
In a recent issue of PharmaVOICE, Dudnyk’s creative wizard, Barry Schmader, argues that today’s tense regulatory environment does not mean the downfall of compelling creative. Barry explains that by utilizing unbranded tactics while fully leveraging the benefits of the digital channel, brands have exciting new options to develop hard-hitting creative while exploring topics that may be risky in branded communications.
Bodenner examines the benefits of independent vs. network agencies
Dudnyk’s SVP, Creative Director, Becky Bodenner, recently voiced her opinions on agency ownership in an article for PM360. She argues, after graciously admitting her bias, that the ability of independent agencies to chart their own course can give them the freedom to develop cutting-edge strategies that the bureaucracy of a global network often restrains. In the end, however, she believes that the creative spirit, values, and vision of an agency truly determine its success regardless of its ownership profile.
Dudnyk creates department of professional services
Dudnyk has formed a new agency department, Professional Services. The department, which is composed of research and editorial, traffic, and corporate communications, will be led by Ellen Schneider, who has been promoted to Vice President.
Frank Powers predicts the rise of Branducation
What’s ahead for pharmaceutical sales as access becomes increasingly draconian and physicians are even less willing to interact with reps? Dudnyk President Frank Powers tells PharmaVOICE that the future lies in nonpersonal and digital interactions, featuring a new breed of selling tools that hold physician attention while demonstrating value.